
Nicole M. Anderson, PhD
Assistant Professor
Department:
SOM-Cell and Molecular Biology
Email:
nanderson1@umc.edu
Work Phone:
(601) 984-2772
Education
University of Toronto, PhD, Genetics/Hematopoietic Disease | 2011 |
University of Waterloo, BS, Biology |
Current Positions
Assistant Professor, School of Medicine | 11/2022 - Present |
The University of Mississippi Medical Center Jackson, Mississippi 39216 |
Publications
Letter | |
Lian H, Li D, Zhou Y, Landesman-Bollag E, Zhang G, Anderson NM, Tang KC, Roderick JE, Kelliher MA, Seldin DC, Fu H, Feng H, CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells. Haematologica, 2017 Jan;102(1):e17-e21 | 2017 |
Anderson NM, Harrold I, Mansour MR, Sanda T, McKeown M, Nagykary N, Bradner JE, Lan Zhang G, Look AT, Feng H, BCL2-specific inhibitor ABT-199 synergizes strongly with cytarabine against the early immature LOUCY cell line but not more-differentiated T-ALL cell lines. Leukemia, 2014 May;28(5):1145-8 | 2014 |
Journal Article | |
Li F, Liu P, Mi W, Li L, Anderson NM, Lesner NP, Burrows M, Plesset J, Majer A, Wang G, Li J, Zhu L, Keith B, Simon MC, Blocking methionine catabolism induces senescence and confers vulnerability to GSK3 inhibition in liver cancer. Nature cancer, 2024 Jan;5(1):131-146 | 2024 |
Missiaen R, Anderson NM, Kim LC, Nance B, Burrows M, Skuli N, Carens M, Riscal R, Steensels A, Li F, Simon MC, GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment. Cell metabolism, 2022 Aug 2;34(8):1151-1167.e7 | 2022 |
Anderson NM, Qin X, Finan JM, Lam A, Athoe J, Missiaen R, Skuli N, Kennedy A, Saini AS, Tao T, Zhu S, Nissim I, Look AT, Qing G, Simon MC, Feng H, Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma. Cancer research, 2021 Sep 1;81(17):4417-4430 | 2021 |
Anderson NM, Simon MC, The tumor microenvironment. Current biology : CB, 2020 Aug 17;30(16):R921-R925 | 2020 |
Anderson NM, Simon MC, BACH1 Orchestrates Lung Cancer Metastasis. Cell, 2019 Jul 11;178(2):265-267 | 2019 |
Huiting LN, Samaha Y, Zhang GL, Roderick JE, Li B, Anderson NM, Wang YW, Wang L, Laroche F, Choi JW, Liu CT, Kelliher MA, Feng H, UFD1 contributes to MYC-mediated leukemia aggressiveness through suppression of the proapoptotic unfolded protein response. Leukemia, 2018 Nov;32(11):2339-2351 | 2018 |
Anderson NM, Mucka P, Kern JG, Feng H, The emerging role and targetability of the TCA cycle in cancer metabolism. Protein & cell, 2018 Feb;9(2):216-237 | 2018 |
Anderson NM, Li D, Peng HL, Laroche FJ, Mansour MR, Gjini E, Aioub M, Helman DJ, Roderick JE, Cheng T, Harrold I, Samaha Y, Meng L, Amsterdam A, Neuberg DS, Denton TT, Sanda T, Kelliher MA, Singh A, Look AT, Feng H, The TCA cycle transferase DLST is important for MYC-mediated leukemogenesis. Leukemia, 2016 Jun;30(6):1365-74 | 2016 |
Harrold I, Carbonneau S, Moore BM, Nguyen G, Anderson NM, Saini AS, Kanki JP, Jette CA, Feng H, Efficient transgenesis mediated by pigmentation rescue in zebrafish. BioTechniques, 2016 Jan;60(1):13-20 | 2016 |
Srinivasan S, Chitalia V, Meyer RD, Hartsough E, Mehta M, Harrold I, Anderson N, Feng H, Smith LE, Jiang Y, Costello CE, Rahimi N, Hypoxia-induced expression of phosducin-like 3 regulates expression of VEGFR-2 and promotes angiogenesis. Angiogenesis, 2015 Oct;18(4):449-62 | 2015 |
Anderson NM, Berberovic Z, Berndl E, Bailey ML, Flenniken AM, Osborne LR, Adamson SL, Rossant J, Wang C, Minden MD, McNagny KM, Paulson RF, Barber DL, Stanford WL, Cytopenia induction by 5-fluorouracil identifies thrombopoietic mutants in sensitized ENU mutagenesis screens. Experimental hematology, 2012 Jan;40(1):48-60 | 2012 |
Hughes MR, Anderson N, Maltby S, Wong J, Berberovic Z, Birkenmeier CS, Haddon DJ, Garcha K, Flenniken A, Osborne LR, Adamson SL, Rossant J, Peters LL, Minden MD, Paulson RF, Wang C, Barber DL, McNagny KM, Stanford WL, A novel ENU-generated truncation mutation lacking the spectrin-binding and C-terminal regulatory domains of Ank1 models severe hemolytic hereditary spherocytosis. Experimental hematology, 2011 Mar;39(3):305-20, 320.e1-2 | 2011 |
Wang CH, Anderson N, Li SH, Szmitko PE, Cherng WJ, Fedak PW, Fazel S, Li RK, Yau TM, Weisel RD, Stanford WL, Verma S, Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate. Circulation research, 2006 Sep 15;99(6):617-25 | 2006 |
Flenniken AM, Osborne LR, Anderson N, Ciliberti N, Fleming C, Gittens JE, Gong XQ, Kelsey LB, Lounsbury C, Moreno L, Nieman BJ, Peterson K, Qu D, Roscoe W, Shao Q, Tong D, Veitch GI, Voronina I, Vukobradovic I, Wood GA, Zhu Y, Zirngibl RA, Aubin JE, Bai D, Bruneau BG, Grynpas M, Henderson JE, Henkelman RM, McKerlie C, Sled JG, Stanford WL, Laird DW, Kidder GM, Adamson SL, Rossant J, A Gja1 missense mutation in a mouse model of oculodentodigital dysplasia. Development (Cambridge, England), 2005 Oct;132(19):4375-86 | 2005 |
Anderson NM, Javadi M, Berndl E, Berberovic Z, Bailey ML, Huang K, Flenniken AM, Osborne LR, Adamson SL, Rossant J, Carter-Su C, Wang C, McNagny KM, Paulson RF, Minden MD, Stanford WL, Barber DL, Enu mutagenesis identifies a novel platelet phenotype in a loss-of-function Jak2 allele. PloS one, 2013;8(9):e75472 |
Presentations
National and International Invited Seminars/Lectures, A MYCN-Driven Zebrafish Model of High-Risk Neuroblastoma Exhibits Early Metastatic Dissemination, ZDM17, Lisbon Portugal | 10/2024 |
State/Local Invited Seminars/Lectures, Utilizing Zebrafish to Model Metastatic Dissemination in High-Risk Neuroblastoma., CRRC, Jackson MS | 03/2024 |
State/Local Invited Seminars/Lectures, Defining Mechanisms of Dissemination and Treatment Resistance in Neuroblastoma, Neuroscience Seminar Series, Jackson MS | 02/2024 |
Regional Invited Seminars/Lectures, DLST, Tumor Aggression, and Bioenergetics in High-Risk Neuroblastoma., Tristate Metabolism Meeting, Princeton NJ | 10/2021 |
National and International Invited Seminars/Lectures, Metabolic Enzyme DLST Drives Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma, Cold Spring Harbor Laboratory Virtual Meeting, Virtual | 10/2021 |
Committee Service
ZDMS - Early Career Investigator Committee, Co-Chair | 2023 - Present |
CMB - Graduate Commitee, Member | 2023 - Present |